GynTect

Schnell zu einer sicheren Diagnose

Die Neuheit für Diagnostiklabore

GynTect.

GynTect.

Sichere Diagnose

Sie haben Fragen zu GynTect?

Wir helfen weiter!

Welcome at oncgnostics GmbH Jena

Reliable cancer diagnosis

Development of molecular assays based on epigenetic biomarkers which allow early and reliable cancer diagnostics – this is the intention of oncgnostics!

Improve diagnosis

Our products should allow an early detection of diseases to substantially inprove therapy success. Notice: if detected early, almost all cancer cases are curable.

News

If you would like us to keep you informed about news related to our company, please sign in for our quarterly newsletter.

Das oncgnostics-Teamoncgnostics GmbH

Oncgnostics GmbH Presents New Clinical Data on GynTect® Precision Diagnostics at EUROGIN 2018

,
Oncgnostics will discuss new clinical data with gynaecological key opinion leaders at EUROGIN 2018 SAN FRANCISCO, CA, USA, November 29, 2018 -- Oncgnostics GmbH presents new clinical data on GynTect® Precision Diagnostics for triage of…
Das oncgnostics-Teamoncgnostics GmbH

Cervical Cancer Screening: oncgnostics Closes further Investment Round

Jena, October 17, 2018 – The Thuringian molecular diagnostics company oncgnostics, which quickly and successfully closed a 750,000 Euros crowd-investing round on Seedmatch early in 2018, now announces the closing of another similarly sized…

oncgnostics GynTect

Our fist product, GynTect®, enables reliable and fast diagnosis of cervical cancer and pre-cancerous stages.

Video in German.